Status:
COMPLETED
Enhanced Recovery After Laparoscopic Colorectal Surgery
Lead Sponsor:
University Hospital of North Norway
Conditions:
Rectal Cancer
Postoperative Pain
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
Investigators would like to test the effects of spinal anesthesia as an adjunct to general anesthesia in patients undergoing laparoscopic abdominoperineal rectal amputation. Investigators hypothesize ...
Detailed Description
Effective pain management after laparoscopic rectal surgery is a fundamental requirement in an enhanced recovery after surgery program (ERAS). Opioids remain the mainstay for postsurgical pain despite...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- \*All patients undergoing laparoscopic abdominoperineal rectal amputation for rectal cancer \* Age 18-100 years are eligible for enrollment in the study.
- Exclusion Criteria
- ASA IV,
- BMI\>35,
- contraindication to spinal analgesia
- allergy to any of the drugs used in this study protocol,
- chronic use of opioids or steroids,
- liver or renal impairment,
- patients scheduled for synchronous laparoscopic liver metastatic surgery
- inability to communicate in Norwegian.
Exclusion
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 7 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05406765
Start Date
January 1 2022
End Date
October 7 2022
Last Update
December 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of North Norway
Tromsø, Troms, Norway, 9038